Research graph
References from Skin Lesion in a Child. Local targets link to admitted publications; unresolved targets remain external evidence.
Pediatric melanoma and atypical melanocytic neoplasms
10.1007/978-3-319-22539-5_15 · 2016 · External reference
Pearls and updates: cutaneous signs of systemic malignancy
10.1097/mop.0000000000001152 · 2022 · External reference
Evaluation and surgical management of pediatric cutaneous melanoma and atypical spitz and non-spitz melanocytic tumors (melanocytomas): a report from Children’s Oncology Group
10.1200/jco.24.01154 · 2025 · External reference
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA)
10.1016/j.beha.2023.101448 · 2023 · External reference
Langerhans cell histiocytosis
10.1182/blood.2019000934 · 2020 · External reference
Blastic plasmacytoid dendritic cell neoplasm in children
10.1016/j.hoc.2020.01.008 · 2020 · External reference
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
10.1038/s41375-023-01968-z · 2023 · External reference
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
10.3324/haematol.2010.026179 · 2010 · External reference
Simultaneous deletion of 3‘ETV6 and 5’EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review
10.1186/s13039-016-0232-1 · 2016 · External reference
Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm
10.1038/leu.2017.101 · 2017 · External reference
Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature
10.1007/s12185-020-03070-x · 2021 · External reference
Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm
10.1056/nejmoa1815105 · 2019 · External reference
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
10.1186/s13045-018-0604-6 · 2018 · External reference
Tagraxofusp: first global approval
10.1007/s40265-019-01087-z · 2019 · External reference
CD123-targeted therapy to achieve negative measurable residual disease in pediatric blastic plasmacytoid dendritic cell neoplasm prior to transplantation
10.1002/pbc.32034 · 2025 · External reference
